| 1Epigallocatechin |
|---|
| 2Catechin |
| 3Epigallocatechin gallate |
| 4Epicatechin gallate |
| 5Catechin gallate |
Compound Name Epigallocatechin |
CID 72277 |
Molecular Formula C15H14O7 |
Molecular Weight 306 |
No. Hydrogen Bond Acceptors 7 |
No. Hydrogen Bond Donors 6 |
Applications
Australian Green Tea (Comellia sinensis)
1135
Separation Mode: Reversed Phase
Reversed Phase
ODS-3
HPLC
Antioxidants
Food & Beverage
Nutraceutical
Biochemical Compound / Nutrient
Analytes
Details
LC Conditions (App ID: 1135)
Column: | ||||||||||
Brand Name: | ||||||||||
Part No: | ||||||||||
Phase Name: ODS-3 | ||||||||||
Elution Type: Isocratic | ||||||||||
Mobile Phase: A: 0.2% Phosphoric Acid B: Acetonitrile C: Tetrahydrofuran | ||||||||||
Gradient Profile:
| ||||||||||
Flow Rate: 1 mL/min | ||||||||||
Temperature: 25°C | ||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 280 nm (22°C) | ||||||||||
Sample Note: SecurityGuard™ Guard Cartridge System extends column lifetime.
- SecurityGuard Cartridges, C18 4 x 3.0mm, 10/Pk Part No.: AJ0-4287
- Holder Part No.: KJ0-4282 |
Order Items Used in This Application
00F-4097-E0
Prodigy 5 µm ODS-3 100 Å, LC Column 150 x 4.6 mm, Ea
Qty:
Similar Applications
search
Epigallocatechin
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Kinetex 1.7 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Kinetex 2.6 µm XB-C18 100 Å, LC Column 100 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Luna 3 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Luna 3 µm PFP(2) 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Luna 3 µm Phenyl-Hexyl 100 Å, LC Column 20 x 2 mm, MercuryMS, Ea
Reversed Phase
Luna 3 µm C18(2) 100 Å, LC Column 20 x 2 mm, MercuryMS, Ea
Reversed Phase
Luna 3 µm C18(2) 100 Å, LC Column 20 x 4 mm, MercuryMS, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
